Skip to content

Drug Developer's Intelligence Report

GLOBAL ONCOLOGY CLINICAL Drug Developers

2021

A Comprehensive Report for decision making

1009

Oncology Clinical Stage Drug Developers

It is an excellent report that has a wide variety of oncology information all in one place.

- Dr. Oleh Denysyk

Report Covers all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

Oncology Clinical Drug Developers 2021, is designed to identify clinical stage drug developer’s technologies, Management expertise, Funding and Partnering capabilities. It clearly demark individual company’s clinical pipeline and its emerging early stage oncology research pipeline. 

Report clearly puts top 50 large pharma companies oncology pipeline with mid and small size innovation driven pharma companies, and thus provides clear M&A target companies/molecules landscape. The Report covers 178 companies from Chinese region, thus provide an update on the emergence of this region in Oncology Drug Discovery. 

clinical Oncology drug intelligence 2021
largest coverage

providing intelligence at fingertips

Countries
1

Worldwide 33 Countries Covered. Largest Coverage Guaranteed

Drug developers
1

1009 Active Clinical Stage Oncology Companies Profiled. 

Molecules in Development
1 +

Individual Drug Mechanism of Action & Drug Target

Cancer Targets
1 +

Covers complete Emerging Cancer Drug Targets Details with Numerous Technologies

intelligence supercharged

1202 pages - full of insights

[real3dflipbook id="2"]

Limited Time Offer Save 20% (Year-end Promotion)